Cardioneuroablation for Bradyarrhythmia
Recruiting
N/A
Interventional Study
Bradycardia
Syncope
Sick Sinus Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 106 (estimated)
- Sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter prospective randomized blind controlled trial with a sham procedure group of the efficacy and safety of cardioneuroablation as a method of treating symptomatic bradycardia without a permanent pacemaker implantation
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Any of the following variants of bradyarrhythmia in patients aged 18-65 years:
(1.1.) Symptomatic sinus bradycardia or bradycardia due to atrioventricular blockade, including transient.
(1.2.) Severe asymptomatic sinus bradycardia with a rhythm frequency of \<30 beats…
Contacts